May 12, 2014 8:40am EDT Tonix Pharmaceuticals Completes Enrollment in BESTFIT Trial of TNX-102 SL for Fibromyalgia
Apr 1, 2014 8:45am EDT Tonix Pharmaceuticals Appoints Donald J. Kellerman Senior Vice President, Clinical Development and Regulatory Affairs
Mar 31, 2014 9:15am EDT Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results
Mar 3, 2014 9:35am EST Tonix Pharmaceuticals Completes Pre-IND Meeting With FDA on TNX-201 for Episodic Tension-Type Headache: Clinical Development to Begin in 4Q 2014
